Decision Aid Efficacy in Low Risk Thyroid Cancer
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT07536412
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Differentiated Thyroid Cancer (DTC)
- Papillary Thyroid Carcinoma
- Papillary Thyroid Microcarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Decision Aid — OTHERDecision aid developed by Pitt \& Saucke (2020) called CQUPLE (chart \& question prompt list)
Study Details
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.
Key Dates
- Start date
- May 15, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 15, 2028
- Completion
- Jun 15, 2029
Study Design
- Enrollment
- 34 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: All ParticipantsAll participants receive the intervention (decision aid)
Primary Outcome Measure
Decisional Conflict [ Time Frame: (1) Baseline, (2) after receiving decision aid (approx Day 1 to Day 30), and (3) after going to surgeon clinic appointment (approx Day 2 to Day 45) ]
Central Contacts
- Yinin Hu, MD630-854-0191
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Maryland, Baltimore | Baltimore | Maryland | 21210 |
Find similar trials in Baltimore, MD
Related Studies
- Active Surveillance of Papillary Thyroid MicrocarcinomaRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- RFA Treatment for Papillary Thyroid MicrocarcinomaRecruiting · Columbia University · New York, New York